InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
5
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Gennadios Aristippos, Président Softgel et Oral Tech. Insider active across 1 company, notably Catalent, Inc.. Cumulatively, 16 reports have been published. Split: 0 buy · 5 sells. Total volume traded: €199k. Activity tracked since 26 July 2021. The latest transaction was disclosed on 2 August 2024 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations16 total
113,724 sharesCommon StockSEC:0000950170-24-137791:0
1,169 shares@ US$59.553.1% of flowCommon StockSEC:0001596783-24-000066:0
18,746 shares0Common StockSEC:0001596783-24-000045:0
1,505 shares0Common StockSEC:0001596783-23-000219:0
1,590 shares0Common StockSEC:0001596783-23-000197:0
1,590 shares0Common StockSEC:0001596783-23-000098:0
61 shares@ US$46.580.1% of flowCommon StockSEC:0001596783-23-000054:0
6,771 shares0Common StockSEC:0001596783-22-000115:0
403 shares@ US$106.902.0% of flowCommon StockSEC:0001596783-22-000067:0
18,689 shares@ US$107.0290.6% of flowCommon StockSEC:0001596783-22-000047:0
4,017 shares0Common StockSEC:0001596783-22-000009
4,017 shares0Common StockSEC:0001596783-22-000009:0
8,008 shares0Common StockSEC:0001596783-21-000125
8,008 shares0Common StockSEC:0001596783-21-000125:0
465 shares@ US$113.052.1% of flowCommon StockSEC:0001596783-21-000093
465 shares@ US$113.0550.0% of flowCommon StockSEC:0001596783-21-000093:0
16 of 16 declarations
About Gennadios Aristippos
Gennadios Aristippos is the President Softgel & Oral Tech at Catalent, Inc. He oversees the operations and strategy of this division, which focuses on developing pharmaceutical solutions. His role is essential in ensuring innovation and product quality.
